Zobrazeno 1 - 10
of 106
pro vyhledávání: '"Moderate hemophilia A"'
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Publikováno v:
Science & Sports. 36:390-398
Summary Introduction Some studies suggest that an acute exercise bout can improve the hemostatic process in patients with hemophilia A (HA). No interventional studies have been carried out to assess the influence of endurance training on this effect.
Autor:
María Teresa Álvarez Román, Hortensia de la Corte Rodríguez, Santiago Bonanad Boix, María Eva Mingot‐Castellano, Nuria Fernández Mosteirín, Mónica Martín Salces, Felipe Querol, Mariana Canaro, Amparo Santamaría, Ramiro Núñez, Luis Javier García Frade, Carlo Martinoli, Hae Kyung Kim, Víctor Jiménez‐Yuste
Publikováno v:
Journal of Thrombosis and Haemostasis. 19:2638-2641
Publikováno v:
Kachestvennaya Klinicheskaya Praktika = Good Clinical Practice. :22-29
Objective: to review the data on the efficacy and consumption of octocog alfa and rurioctoctog alfa pegol in standard prophylaxis and individualized prophylaxis in hemophilia A patients based on published international data.Material and methods: a sy
Autor:
Katayoun Karimi, Mohammad Reza Managhchi, Ali Arabkhazaeli, Gholamreza Toogeh, Sanaz Homayoun, Fatemeh Vosough, Minoo Ahmadinejad
Publikováno v:
Blood Coagulation & Fibrinolysis. 31:530-535
Diagnosis of hemophilia A is generally based on the measurement of plasma factor VIII activity (FVIII:C) using the one-stage assay (OSA) or the two-stage chromogenic substrate assay (CSA). The results of these methods show considerable discrepancy in
Autor:
Roza Chaireti, Danijela Mikovic, David E. Schmidt, Maria Bruzelius, Nida Mahmoud Hourani Soutari, Liselotte Onelöv, Annelie Strålfors, Margareta Holmström, Maria Berndtson, Jovan P. Antovic
Publikováno v:
Thrombosis and Haemostasis. 121:027-035
Background Factor VIII (FVIII) activity (FVIII:C) can be measured by different methods including one-stage clotting assays (OSAs) and chromogenic assays (CSAs). Discrepancy between FVIII:C assays is known and associated with genetic variations causin
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Publikováno v:
International Journal of Immunopathology and Pharmacology
Neutralizing antibodies (inhibitors) against factor VIII/IX (FVIII/FIX) poses a serious and challenging complication in the hemophilia treatment. Allergic reaction is more common in hemophilia B and always companion with FIX inhibitors, but it is rar
Autor:
Michael T. Stobb, Dougald M. Monroe, Kathryn G. Link, Aaron L. Fogelson, Keith B. Neeves, Suzanne Sindi, Karin Leiderman
Publikováno v:
Arterioscler Thromb Vasc Biol
Bleeding frequency and severity within clinical categories of hemophilia A are highly variable and the origin of this variation is unknown. Solving this mystery in coagulation requires the generation and analysis of large data sets comprised of exper
Publikováno v:
Journal of Pediatric Hematology/Oncology. 42:e683-e685
In patients with hemophilia, the usual treatment for both iliopsoas hematoma and associated femoral nerve compression is conservative. The case presented herein is a moderate hemophilia A patient with significant femoral neuropathy due to iliopsoas h